Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)

被引：0

作者：

Thibaut Caruba

Delphine Hourton

Brigitte Sabatier

Dominique Rousseau

Annick Tibi

Cécile Hoffart-Jourdain

Akim Souag

Nelly Freitas

Mounia Yjjou

Carla Almeida

Nathalie Gomes

Pascaline Aucouturier

Juliette Djadi-Prat

Philippe Menasché

Gilles Chatellier

Bernard Cholley

机构：

[1] Hôpital Européen Georges Pompidou,Department of Pharmacy

[2] AP-HP,Clinical Trial Unit and INSERM CIC

[3] Hôpital Européen Georges Pompidou,141

[4] AP-HP,Department of Anaesthesiology and Intensive Care

[5] Agence Générale des Equipements et des Produits de Santé (AGEPS),Department of Cardiovascular Surgery

[6] AP-HP,Département de la Recherche Clinique et du Développement (DRCD)

[7] Hôpital Européen Georges Pompidou,undefined

[8] AP-HP,undefined

[9] Hôpital Européen Georges Pompidou,undefined

[10] AP-HP,undefined

[11] Université Paris Descartes,undefined

[12] Sorbonne Paris Cité,undefined

[13] INSERM Centre de Recherche des Cordeliers UMR S 872 eq 22 Université Paris Descartes,undefined

[14] Hôpital Saint-Louis,undefined

[15] (AP-HP),undefined

来源：

Journal of Cardiothoracic Surgery | / 11卷

关键词：

Coronary artery bypass graft; Low cardiac output syndrome; High risk surgical patient; Levosimendan; Cardiac surgery; Perioperative management;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 38 条

[31] Design and Rationale of the APELOT Trial A Randomized, Open-Label, Multicenter, Phase IV Study to Evaluate the Antiplatelet Effect of Different Loading Dose of Ticagrelor in Patients With Non-ST Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Liu, Hui-Liang
Wei, Yu-Jie
Jin, Zhi-Geng
Zhang, Jiao
Ding, Peng
Yang, Sheng-Li
Luo, Jian-Ping
Ma, Dong-Xing
Liu, Ying
Han, Wei
MEDICINE, 2016, 95 (22)
[32] Rationale, design and baseline characteristics of the PROJECT II study: PROpofol CardioproTECTion for Type II diabetics A randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery
Ansley, David M.
Raedschelders, Koen
Chen, David D. Y.
Choi, Peter T.
CONTEMPORARY CLINICAL TRIALS, 2009, 30 (04) : 380 - 385
[33] Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design
Miki Imazu
Atsushi Nakano
Shin Ito
Toshimitsu Hamasaki
Masafumi Kitakaze
Cardiovascular Drugs and Therapy, 2019, 33 : 363 - 370
[34] Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design
Imazu, Miki
Nakano, Atsushi
Ito, Shin
Hamasaki, Toshimitsu
Kitakaze, Masafumi
CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (03) : 363 - 370
[35] Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial
Francisco A. H. Fonseca
Maria Cristina Izar
Ieda M. L. Maugeri
Otavio Berwanger
Lucas P. Damiani
Ibraim M. Pinto
Gilberto Szarf
Carolina N. França
Henrique T. Bianco
Flavio T. Moreira
Adriano Caixeta
Claudia M. R. Alves
Aline Soriano Lopes
Aline Klassen
Marina F. M. Tavares
Henrique A. Fonseca
Antonio C. C. Carvalho
Trials, 18
[36] Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial
Fonseca, Francisco A. H.
Izar, Maria Cristina
Maugeri, Ieda M. L.
Berwanger, Otavio
Damiani, Lucas P.
Pinto, Ibraim M.
Szarf, Gilberto
Franca, Carolina N.
Bianco, Henrique T.
Moreira, Flavio T.
Caixeta, Adriano
Alves, Claudia M. R.
Lopes, Aline Soriano
Klassen, Aline
Tavares, Marina F. M.
Fonseca, Henrique A.
Carvalho, Antonio C. C.
TRIALS, 2017, 18
[37] Rationale and design of TeraViC-4 study:: A phase III, randomized clinical trial to evaluate the effects of treatment duration with peginterferon alfa-2a (40-kDa) and ribavirin in naive patients with chronic hepatitis C virus infection without early virological response at week 4
Sánchez-Tapias, JM
Crespo, J
Diago, M
Pérez, R
Romero-Gómez, M
Muñoz-Sánchez, M
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2002, 24 (09): : 579 - 584
[38] Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2x2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment
Huang, Yining
Sharma, Vijay K.
Robinson, Thompson
Lindley, Richard I.
Chen, Xiaoying
Kim, Jong Sung
Lavados, Pablo
Olavarria, Veronica
Arima, Hisatomi
Fuentes, Sully
Huy Thang Nguyen
Lee, Tsong-Hai
Parsons, Mark W.
Levi, Christopher
Demchuk, Andrew M.
Bath, Philip M. W.
Broderick, Joseph P.
Donnan, Geoffrey A.
Martins, Sheila
Pontes-Neto, Octavio M.
Silva, Federico
Pandian, Jeyaraj
Ricci, Stefano
Stapf, Christian
Woodward, Mark
Wang, Jiguang
Chalmers, John
Anderson, Craig S.
INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (05) : 778 - 788

← 1 2 3 4 →